Market News

Changes since the financial crisis should have investors repricing risk for banks--and raising valuations.

A swift drop in China shares Wednesday eased slightly, with two-day losses just shy of 10%, a signal that the market is testing when and whether Beijing will step in to steady shares.

A judge on Wednesday paved the way for nearly 100% recoveries for creditors of MF Global's brokerage, an outcome considered unthinkable when the firm collapsed less than four years ago.

I really don?t like dumping on MannKind nor do I take any great pleasure in watching shares slide. Yet it is fun to read the things MannKind supporters write, how they explain in spite of those pesky facts that MannKind ...

The U.S. Federal Reserve may wait until after September to lift interest rates after the latest minutes from the central bank's July meeting indicated conditions for the first rates increase in about a decade had not bee...

Fast-growing online lender Social Finance has raised about another $1 billion from investors, giving the startup a roughly $4 billion valuation that would place it in the top 30 U.S. banks by market capitalization.

Fannie Mae's and Freddie Mac's regulator won't push the mortgage companies to direct additional lending resources to low-income borrowers, a blow to affordable-housing advocates.

Investment banks are riding out the roughest spell in Southeast Asia in six years as IPOs are scrapped, mergers falter and foreign investors shy away from local stocks and bonds.

In recent months, I've highlighted companies with lengthy histories of raising their dividends year after year. That quality adds to the compounding achieved by investing through dividend reinvestment plans (DRIPs) , whi...

Sluggish growth in infra and real estate sectors in India adds to pressure on domestic commodity prices

China’s recent move to devalue its currency has shocked world markets. But it’s less of a shock if one keeps in mind what economist Hyman Minsky taught us about financial fragility and economic instability.

Looking at the sectors faring worst as of midday Wednesday, shares of Energy companies are underperforming other sectors, showing a 2.3% loss. Within that group, Marathon Oil Corp. (NYSE: MRO) and Anadarko Petroleum Corp...

Looking at the sectors faring best as of midday Wednesday, shares of Utilities companies are outperforming other sectors, higher by 0.6%. Within that group, Exelon Corp. (NYSE: EXC) and Edison International (NYSE: EIX) a...

Salesforce.com needs to keep selling big to justify its premium valuation.

Xcel Energy (XEL) declared a quarterly dividend on its common stock of 32 cents per share. The dividends are payable October 20, 2015, to shareholders of record on September 17, 2015.

The PowerShares Russell 1000 Equal Weight Portfolio ETF (EQAL) is seeing unusually high volume in afternoon trading Wednesday, with over 91,000 shares traded versus three month average volume of about 28,000. Shares of E...

In trading on Wednesday, the Junior Gold Miners ETF (GDXJ) is outperforming other ETFs, up about 1.4% on the day. Components of that ETF showing particular strength include shares of Alamos Gold (AGI), up about 8.3% and ...

In trading on Wednesday, oil & gas exploration & production shares were relative laggards, down on the day by about 5.3%. Helping drag down the group were shares of Baytex Energy Corporation (BTE), off about 15.4% and sh...

In trading on Wednesday, precious metals shares were relative leaders, up on the day by about 1.9%. Leading the group were shares of Banro (BAA), up about 8.3% and shares of Anglogold Ashanti (AU) up about 8% on the day.

Ericsson has long been a leader in the global mobile infrastructure market, holding a market share of over 30%. However, its share has declined over the past three years due to a technology shift from CDMA to 3G-4G/LTE a...

Improved operating results for major U.S. banks, coupled with continued efforts by the banks to clean up their balance sheets, have resulted in a sizable increase in common equity tier 1 (CET1) ratio figures for the indu...

Well, here is a fun fact for you. Around 20-25% of Bristol-Myers Squibb?s valuation is based on the expected growth of its cancer drugs, primarily Yervoy and Nivolumab. In other words, if the growth in these drugs was to...